Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School
Dr. Juan Ding received her B.S. degree from Tsinghua University, Beijing, China in 2004. She then studied in the Molecular and Cellular Biology program under the supervision of Dr. John Kopchick at Ohio University and received her Ph.D. in 2009. Her Ph.D. dissertation unraveled biomarkers of growth hormone and aging in a series of mouse models that showed excess or disrupted growth hormone signaling. As a post doctoral research associate, Dr. Ding focused on detecting growth hormone doping and discovered novel biomarkers of recombinant human growth hormone administration in healthy human subjects. Dr. Ding has published many original research articles as well as reviews and a book chapter on growth hormone, aging, proteomics and molecular biology. Currently Dr. Ding is working at Schepens Eye Research Institute at Harvard medical school to unravel the endocrine regulation of meibomian gland in dry eye disease.
Dr. Ding is interested in the endocrine regulation of aging and age-related diseases. Her current research focuses on dry eye disease, which affects 3 million Americans and is more prevalent among the elderly. Specifically, Dr. Ding is interested in unraveling the molecular mechanism of the pathophysiology induced by retinoic acid, with the objective of identifying therapeutic targets to treat dry eye disease.